Biotech Startups

Solaria develops plant-sourced living synbiotics (probiotic-prebiotic products) marketed as medical foods for inflammatory conditions, starting with Bōndia for bone loss in women with osteopenia and a forthcoming product, Arthrīva, for rheumatoid arthritis. The company builds a library of plant-based microbiome solutions backed by clinical trials and a Harvard Medical School partnership.

1 investor

Solaris Pharma develops and supplies generic and specialty pharmaceutical products including topical, sterile, and tablet formulations. The company serves patients seeking high-quality, affordable therapeutic alternatives with an emphasis on regulatory compliance and manufacturing reliability.

1 investor

SolasCure is developing mechanism-driven therapeutics to address biological barriers in chronic wound healing, with its lead candidate Aurase Wound Gel completing Phase II clinical trials. The company serves clinicians and healthcare systems seeking clinically validated approaches to improve outcomes for patients with non-healing or slowly healing wounds.

1 investor

Solgate is a drug discovery company developing small-molecule drugs that target solute carrier (SLC) membrane transporter proteins, using a platform combining chemical, biological, and computational technologies. A spin-off from CeMM/ÖAW and IST Austria, it focuses on advancing a pipeline of SLC-targeting compounds toward clinical development for human disease.

1 investor

1 investor

Solis Agrosciences is an agricultural science company with a team focused on molecular sciences, plant transformation, and plant research. It employs scientists and research associates working in areas such as greenhouse work and plant biotechnology.

1 investor

Solvamed GmbH develops medical devices for the prevention and diagnosis of infections, with current research focused on preventing catheter sepsis (CutSep) and non-invasive sampling for respiratory infectious diseases. The company, a medical device manufacturer founded in 2013, is based in Rostock, Germany, and conducts research and development projects toward clinical approval studies.

1 investor

SolvEat is a food-tech company that develops clinically validated bioactive botanical ingredient compositions, using microencapsulation to add functional health benefits to everyday foods like chocolate, snacks and beverages. It serves food and beverage manufacturers seeking to create wellness-oriented products that target specific health conditions.

1 investor

Energy Solutions SaaS for Businesses

1 investor

Solynta develops non-GMO hybrid breeding technology for potatoes, enabling faster variety development with enhanced disease resistance and climate adaptability. The company serves potato growers and food security initiatives across more than 40 countries, focusing on sustainable agricultural productivity.

1 investor

Somagenetix is a gene therapy company that develops treatments for genetic diseases, particularly phagocyte-driven immune and neurodegenerative disorders, by correcting DNA at its source. Founded as a spin-out of the University of Zurich, the company aims to deliver one-time curative treatments for previously incurable genetic conditions.

1 investor

SonALAsense develops Sonodynamic Therapy (SDT), a non-invasive drug-device cancer treatment combining its SONALA-001 drug with an ultrasound device to treat deadly cancers such as High-Grade Gliomas and DIPG. The company is running Phase 0/1 and Phase 1/2 clinical trials and targets patients with brain tumors that typically require surgery.

1 investor

SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound enhancing agents) to deliver genetic payloads to targeted sites in a redosable manner. The company works in genetic medicine, aiming to overcome delivery limitations related to biodistribution, safety, immunogenicity, durability, and cost.

1 investor

Sophie's Bionutrients develops plant-based protein alternatives using microalgae and bioreactor technology for the food industry. The company creates sustainable, ocean-derived nutrients without animal farming for food manufacturers and consumers.

1 investor

1 investor

Sophomer develops polymeric materials designed to replace bovine serum albumin in immunochemical assays. The company serves laboratories and research organizations conducting immunological analytics and ELISA assays.

1 investor

Sorriso Pharma is a biopharmaceutical company backed by leading venture capital firms specializing in life sciences and healthcare investments.

1 investor

Soterius provides drug safety, pharmacovigilance, and medical affairs services to pharmaceutical companies, including case intake and processing, signal detection, aggregate report writing, and compliance technology. It serves top pharma firms globally with safety experts, QPPVs, and Local Safety Managers across 60+ countries.

1 investor

Sound Wave Innovation develops therapeutic treatment technologies based on acoustic and shock wave applications for medical treatment. The company aims to lead in advanced therapeutic applications of sound waves to address unmet medical needs and improve global health.

1 investor

Southern Star Research conducts clinical trials in reproductive and sexual health, partnering with sponsors to design and deliver Phase I and Phase II studies. The company focuses on patient-centered research across Australia and Asia-Pacific regions, with expertise in managing sensitive data, participant recruitment, and regulatory compliance in these therapeutic areas.

1 investor

Space Tango develops automated platforms for research and manufacturing in microgravity environments, operating facilities on the International Space Station and other off-Earth locations from low Earth orbit to lunar missions. The company enables space-based tissue engineering, materials creation, and health research aimed at accelerating therapies and strengthening supply chains.

1 investor

SpacePharma develops pharmaceutical research and manufacturing systems designed to operate in microgravity environments aboard satellites and spacecraft. The company uses space-based platforms to conduct drug crystallization, organ-on-chip testing, and other biomedical research that benefits from microgravity conditions.

1 investor

One-time gene therapy products including a candidate for RPE65-related blindness. (NASDAQ: ONCE) (Acquired by Roche)

1 investor

Sparta Biomedical develops chemically engineered cartilage implants built on its Hyalos hydrogel platform, including Karthyx, an MTP hemiarthroplasty device that combines the cartilage-mimicking hydrogel with a titanium fixation technology. The company targets treatment of joint cartilage degeneration and osteoarthritis through cartilage-like implants for joints such as the great toe.

1 investor